Tarsus Pharmaceuticals stockTARS
Tarsus Pharmaceuticals trades at $67.52, 26.2% below its 52-week high (Sep 4, 2026). The price is below its 50- and 200-day averages, a downtrend. −17.5% year to date, −1.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for TARS — after you log in
Open the terminalFrequently asked questions about Tarsus Pharmaceuticals
What is the Tarsus Pharmaceuticals stock price?
At the close on Nov 5, 2026: $67.52 (−2.24% on the day). 52-week high: $91.53 on Sep 4, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Tarsus Pharmaceuticals report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed −4,700% year over year, revenue +64%.
Does Tarsus Pharmaceuticals pay dividends?
No, Tarsus Pharmaceuticals does not pay dividends.
Where does Tarsus Pharmaceuticals trade and how to buy it?
Ticker TARS, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Tarsus Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for TARS are in the terminal after you log in.